HealthDay reported a new study found that “providing nonsurgical periodontal treatment to patients with type 2 diabetes (T2D) and periodontitis may significantly reduce tooth loss and diabetes-related microvascular diseases via improved glycemic control.” In the study, researchers “built a microsimulation model to evaluate the cost-effectiveness of expanding periodontal treatment coverage among patients with T2D,” finding “expanding periodontal treatment coverage among patients with T2D and periodontitis would avert tooth loss by 34.1 percent and microvascular diseases by 20.5 percent for nephropathy, 17.7 percent for neuropathy, and 19.2 percent for retinopathy.” The findings were published in Diabetes Care.
